Trevi Therapeutics, Inc. - Common Stock (TRVI)
CUSIP: 89532M101
Q3 2021 13F Holders as of 30 Sep 2021
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 128,120,714
- Total 13F shares
- 12,448,249
- Share change
- -30,248
- Total reported value
- $17,424,000
- Price per share
- $1.40
- Number of holders
- 15
- Value change
- -$63,952
- Number of buys
- 4
- Number of sells
- 4
Quarterly Holders Quick Answers
What is CUSIP 89532M101?
CUSIP 89532M101 identifies TRVI - Trevi Therapeutics, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 89532M101:
Top shareholders of TRVI - Trevi Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| NEA Management Company, LLC |
13F
|
Company |
4.6%
|
5,940,796
|
$13,367,000 | — | 30 Jun 2021 | |
| TPG Group Holdings (SBS) Advisors, Inc. |
13F
|
Company |
3.8%
|
4,824,883
|
$10,856,000 | — | 30 Jun 2021 | |
| Omega Fund Management, LLC |
13F
|
Company |
0.99%
|
1,263,408
|
$2,843,000 | — | 30 Jun 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.1%
|
133,215
|
$300,000 | — | 30 Jun 2021 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.07%
|
92,600
|
$208,000 | — | 30 Jun 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.04%
|
49,077
|
$110,000 | — | 30 Jun 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.03%
|
44,180
|
$99,000 | — | 30 Jun 2021 | |
| WealthTrust Axiom LLC |
13F
|
Company |
0.03%
|
39,500
|
$88,000 | — | 30 Jun 2021 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.03%
|
34,600
|
$78,000 | — | 30 Jun 2021 | |
| Alberta Investment Management Corp |
13F
|
Company |
0.02%
|
25,000
|
$56,000 | — | 30 Jun 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.01%
|
11,414
|
$26,000 | — | 30 Jun 2021 | |
| LPL Financial LLC |
13F
|
Company |
0.01%
|
10,000
|
$23,000 | — | 30 Jun 2021 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
4,187
|
$10,000 | — | 30 Jun 2021 | |
| FIRST MANHATTAN CO. LLC. |
13F
|
Company |
0%
|
3,500
|
$7,000 | — | 30 Jun 2021 | |
| UBS Group AG |
13F
|
Company |
0%
|
2,137
|
$5,000 | — | 30 Jun 2021 |
Institutional Holders of Trevi Therapeutics, Inc. - Common Stock (TRVI) as of Q3 2021
As of 30 Sep 2021,
Trevi Therapeutics, Inc. - Common Stock (TRVI) was held by
15 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,448,249 shares.
The largest 10 holders included
NEA Management Company, LLC, TPG Group Holdings (SBS) Advisors, Inc., Omega Fund Management, LLC, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock Inc., WealthTrust Axiom LLC, BRIDGEWAY CAPITAL MANAGEMENT, LLC, and CITADEL ADVISORS LLC.
This page lists
15
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2021 vs Q2 2021 Across Filers
Q2 2021 holders
15
Q3 2021 holders
15
Holder diff
0
| Investor | Q2 2021 Shares | Q3 2021 Shares | Share Diff | Share Chg % | Q2 2021 Value $ | Q3 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.